14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $199.92 $199.92 Thursday, 14th Sep 2023 RXDX stock ended at $199.92. During the day the stock fluctuated 0% from a day low at $199.92 to a day high of $199.92.
90 days $199.92 $199.92
52 weeks $30.75 $199.96

Historical Prometheus Biosciences Inc prices

Date Open High Low Close Volume
Oct 20, 2022 $47.28 $49.50 $47.17 $48.72 310 485
Oct 19, 2022 $48.57 $48.72 $46.08 $47.06 416 232
Oct 18, 2022 $48.76 $50.50 $48.03 $48.62 542 533
Oct 17, 2022 $48.28 $48.80 $47.13 $48.14 843 700
Oct 14, 2022 $49.50 $50.28 $47.23 $47.36 506 264
Oct 13, 2022 $49.60 $50.40 $48.01 $49.21 814 381
Oct 12, 2022 $50.85 $51.80 $49.55 $50.95 313 193
Oct 11, 2022 $53.09 $53.31 $50.11 $50.85 586 582
Oct 10, 2022 $54.34 $55.67 $52.09 $53.09 447 485
Oct 07, 2022 $54.89 $57.53 $54.20 $55.04 577 256
Oct 06, 2022 $59.46 $60.94 $54.73 $55.68 743 221
Oct 05, 2022 $58.71 $60.05 $56.49 $59.48 379 607
Oct 04, 2022 $61.50 $62.11 $58.17 $59.57 663 555
Oct 03, 2022 $61.08 $61.83 $58.89 $60.00 483 349
Sep 30, 2022 $57.73 $63.13 $57.47 $59.01 760 600
Sep 29, 2022 $57.74 $58.23 $54.16 $57.54 434 011
Sep 28, 2022 $53.90 $58.78 $53.88 $58.25 690 395
Sep 27, 2022 $51.55 $53.83 $51.48 $53.53 356 269
Sep 26, 2022 $50.80 $52.65 $50.34 $50.52 305 437
Sep 23, 2022 $51.62 $52.48 $49.59 $50.84 527 074
Sep 22, 2022 $52.32 $52.87 $50.74 $52.22 417 716
Sep 21, 2022 $56.91 $57.95 $52.60 $52.62 379 389
Sep 20, 2022 $53.98 $56.73 $53.34 $56.58 463 470
Sep 19, 2022 $54.07 $55.19 $52.39 $54.38 533 806
Sep 16, 2022 $55.83 $56.45 $53.09 $55.47 3 174 418
Click to get the best stock tips daily for free!

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT